Mike Watson | Snr Director of Business Development
Nucleus Network

Mike Watson, Snr Director of Business Development, Nucleus Network

Mike Watson is the Senior Director of Business Development for Nucleus Network, the largest Phase 1 Group in Australia with 2 sites and 150 beds.   Nucleus Network provides First in Human clinical studies in numerous indications that includes vaccines. Mike is retired from the US Navy having served 20 years.  He has been in the CRO Business Development space for 15 years with experience in pre-clinical Toxicology and Phase 1-4 clinical studies.


Day 2, April 8 @ 14:40

The advantages of conducting early phase clinical trials in Australia

last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates